vs

Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and SEMTECH CORP (SMTC). Click either name above to swap in a different company.

SEMTECH CORP is the larger business by last-quarter revenue ($267.0M vs $164.7M, roughly 1.6× PTC THERAPEUTICS, INC.). SEMTECH CORP runs the higher net margin — -1.1% vs -82.0%, a 80.9% gap on every dollar of revenue. On growth, SEMTECH CORP posted the faster year-over-year revenue change (12.7% vs -22.7%). SEMTECH CORP produced more free cash flow last quarter ($44.6M vs $-36.6M). Over the past eight quarters, SEMTECH CORP's revenue compounded faster (17.6% CAGR vs -11.5%).

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

Semtech Corporation is an American supplier of analog and mixed-signal semiconductors and advanced algorithms for consumer, enterprise computing, communications and industrial end-markets. It is based in Camarillo, Ventura County, Southern California. It was founded in 1960 in Newbury Park, California. It has 32 locations in 15 countries in North America, Europe, and Asia.

PTCT vs SMTC — Head-to-Head

Bigger by revenue
SMTC
SMTC
1.6× larger
SMTC
$267.0M
$164.7M
PTCT
Growing faster (revenue YoY)
SMTC
SMTC
+35.5% gap
SMTC
12.7%
-22.7%
PTCT
Higher net margin
SMTC
SMTC
80.9% more per $
SMTC
-1.1%
-82.0%
PTCT
More free cash flow
SMTC
SMTC
$81.3M more FCF
SMTC
$44.6M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
SMTC
SMTC
Annualised
SMTC
17.6%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
PTCT
PTCT
SMTC
SMTC
Revenue
$164.7M
$267.0M
Net Profit
$-135.0M
$-2.9M
Gross Margin
51.9%
Operating Margin
-43.3%
11.6%
Net Margin
-82.0%
-1.1%
Revenue YoY
-22.7%
12.7%
Net Profit YoY
-104.8%
62.3%
EPS (diluted)
$-1.63
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTCT
PTCT
SMTC
SMTC
Q4 25
$164.7M
$267.0M
Q3 25
$211.0M
$257.6M
Q2 25
$178.9M
$251.1M
Q1 25
$1.2B
$251.0M
Q4 24
$213.2M
$236.8M
Q3 24
$196.8M
$215.4M
Q2 24
$186.7M
$206.1M
Q1 24
$210.1M
$192.9M
Net Profit
PTCT
PTCT
SMTC
SMTC
Q4 25
$-135.0M
$-2.9M
Q3 25
$15.9M
$-27.1M
Q2 25
$-64.8M
$19.3M
Q1 25
$866.6M
$39.1M
Q4 24
$-65.9M
$-7.6M
Q3 24
$-106.7M
$-170.3M
Q2 24
$-99.2M
$-23.2M
Q1 24
$-91.6M
$-642.4M
Gross Margin
PTCT
PTCT
SMTC
SMTC
Q4 25
51.9%
Q3 25
52.1%
Q2 25
52.3%
Q1 25
52.0%
Q4 24
51.1%
Q3 24
49.0%
Q2 24
48.3%
Q1 24
-0.2%
Operating Margin
PTCT
PTCT
SMTC
SMTC
Q4 25
-43.3%
11.6%
Q3 25
1.4%
-6.3%
Q2 25
-19.5%
14.3%
Q1 25
82.5%
8.5%
Q4 24
-76.2%
7.5%
Q3 24
-27.7%
3.6%
Q2 24
-21.5%
1.5%
Q1 24
-21.6%
-321.3%
Net Margin
PTCT
PTCT
SMTC
SMTC
Q4 25
-82.0%
-1.1%
Q3 25
7.5%
-10.5%
Q2 25
-36.3%
7.7%
Q1 25
73.7%
15.6%
Q4 24
-30.9%
-3.2%
Q3 24
-54.2%
-79.1%
Q2 24
-53.1%
-11.2%
Q1 24
-43.6%
-332.9%
EPS (diluted)
PTCT
PTCT
SMTC
SMTC
Q4 25
$-1.63
$-0.03
Q3 25
$0.20
$-0.31
Q2 25
$-0.83
$0.22
Q1 25
$10.04
$0.81
Q4 24
$-0.85
$-0.10
Q3 24
$-1.39
$-2.61
Q2 24
$-1.29
$-0.36
Q1 24
$-1.20
$-10.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTCT
PTCT
SMTC
SMTC
Cash + ST InvestmentsLiquidity on hand
$1.9B
$164.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$-205.3M
$565.7M
Total Assets
$2.9B
$1.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTCT
PTCT
SMTC
SMTC
Q4 25
$1.9B
$164.7M
Q3 25
$1.7B
$168.6M
Q2 25
$2.0B
$156.5M
Q1 25
$2.0B
$151.7M
Q4 24
$1.1B
$136.5M
Q3 24
$1.0B
$115.9M
Q2 24
$1.1B
$126.8M
Q1 24
$884.8M
$128.6M
Stockholders' Equity
PTCT
PTCT
SMTC
SMTC
Q4 25
$-205.3M
$565.7M
Q3 25
$-155.8M
$552.9M
Q2 25
$-206.5M
$568.8M
Q1 25
$-185.8M
$542.4M
Q4 24
$-1.1B
$-139.7M
Q3 24
$-1.1B
$-141.4M
Q2 24
$-980.2M
$-313.1M
Q1 24
$-893.9M
$-307.4M
Total Assets
PTCT
PTCT
SMTC
SMTC
Q4 25
$2.9B
$1.4B
Q3 25
$2.6B
$1.4B
Q2 25
$2.6B
$1.4B
Q1 25
$2.7B
$1.4B
Q4 24
$1.7B
$1.4B
Q3 24
$1.8B
$1.4B
Q2 24
$1.9B
$1.4B
Q1 24
$1.8B
$1.4B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTCT
PTCT
SMTC
SMTC
Operating Cash FlowLast quarter
$-34.3M
$47.5M
Free Cash FlowOCF − Capex
$-36.6M
$44.6M
FCF MarginFCF / Revenue
-22.3%
16.7%
Capex IntensityCapex / Revenue
1.4%
1.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$702.3M
$143.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTCT
PTCT
SMTC
SMTC
Q4 25
$-34.3M
$47.5M
Q3 25
$-66.3M
$44.4M
Q2 25
$-58.3M
$27.8M
Q1 25
$870.1M
$33.5M
Q4 24
$-30.0M
$29.6M
Q3 24
$-77.0M
$-5.0M
Q2 24
$-71.5M
$-89.0K
Q1 24
$70.8M
$13.9M
Free Cash Flow
PTCT
PTCT
SMTC
SMTC
Q4 25
$-36.6M
$44.6M
Q3 25
$-69.7M
$41.5M
Q2 25
$-59.6M
$26.2M
Q1 25
$868.4M
$30.9M
Q4 24
$-33.8M
$29.1M
Q3 24
$-77.5M
$-8.4M
Q2 24
$-78.8M
$-1.4M
Q1 24
$61.2M
$12.2M
FCF Margin
PTCT
PTCT
SMTC
SMTC
Q4 25
-22.3%
16.7%
Q3 25
-33.1%
16.1%
Q2 25
-33.3%
10.4%
Q1 25
73.8%
12.3%
Q4 24
-15.8%
12.3%
Q3 24
-39.4%
-3.9%
Q2 24
-42.2%
-0.7%
Q1 24
29.1%
6.3%
Capex Intensity
PTCT
PTCT
SMTC
SMTC
Q4 25
1.4%
1.1%
Q3 25
1.6%
1.1%
Q2 25
0.7%
0.7%
Q1 25
0.1%
1.0%
Q4 24
1.8%
0.2%
Q3 24
0.3%
1.6%
Q2 24
4.0%
0.6%
Q1 24
4.6%
0.9%
Cash Conversion
PTCT
PTCT
SMTC
SMTC
Q4 25
Q3 25
-4.17×
Q2 25
1.44×
Q1 25
1.00×
0.86×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PTCT
PTCT

Segment breakdown not available.

SMTC
SMTC

Products$239.5M90%
Services$27.4M10%

Related Comparisons